Image

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

I-SPY TRIAL: Testing new breast cancer treatments before surgery.

Recruiting
18 years and older
All
Phase 2

I-SPY TRIAL is a study to find out which new drugs work best for different types of breast cancer. It uses special tests like MRI scans (pictures of the inside of the body using magnets) and samples of tissue and blood to see how well the treatment is working. This study tries different drugs with regular chemotherapy to see what works better for certain breast cancer types. It looks at the cancer's "biomarker signatures", which are special features of the cancer, to decide the best treatment. If a drug doesn't seem to work well, the study will stop using it. New drugs will be tested as others finish being checked.

  • Participants must be adults (18+) with certain types of breast cancer and meet specific health requirements.
  • They should not have had previous cancer treatments like chemotherapy or radiation for the same cancer.
  • Participants must be willing to provide tissue samples and undergo procedures like MRIs.
Study details
    Breast Neoplasms
    Breast Cancer
    Breast Tumors
    Angiosarcoma
    TNBC - Triple-Negative Breast Cancer
    HER2-positive Breast Cancer
    HER2-negative Breast Cancer
    Hormone Receptor Positive Tumor
    Hormone Receptor Negative Tumor
    Early-stage Breast Cancer
    Locally Advanced Breast Cancer

NCT01042379

QuantumLeap Healthcare Collaborative

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.